The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISTH 2022 | How hemophilia care has changed over the years
Alok Srivastava
• 11 Jul 2022
Alok Srivastava, MD, FRACP, FRCPA, FRCP, Christian Medical College, Vellore, India, comments on how hemophilia care and therapeutic options for patients have changed over the years, drawing focus on the promise of agents such as emicizumab and fitusiran. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.
